Delivery Order SPE2DB25D3002-SPE2DB25FLRLT
- Not listed
- The Defense Logistics Agency awarded a $1,036.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of ZORYVE 0.3% Cream in 60-gram units. This is a non-set-aside contract with an ultimate completion date of April 25, 2025, and performance occurring at the vendor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ZORYVE 0.3% Cream in a 60-gram unit, with a contract ceiling value of $1,088.04. This firm fixed price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by August 7, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in the same city....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ZORYVE 0.3% Cream in a 60-gram quantity, with a contract ceiling value of $2,100.10. This competitively awarded, firm fixed-price delivery order was issued on August 6, 2025, with an ultimate completion date of August 7, 2025. The contract utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,457.92 to AmerisourceBergen Drug Corp for ZORYVE 0.15% Cream (60 grams) on August 25, 2025, with completion expected by August 26, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's distribution facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,548.75 for ZORYVE 0.3% Cream (60GM) on September 5, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract supporting federal medical procurement needs. The award is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- On June 2, 2025, the Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,858.71 for ZORYVE 0.15% Cream in 60-gram quantities. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of June 3, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order operates under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitive delivery order award from the Defense Logistics Agency on April 29, 2025, for ZORYVE 0.3% Cream in a 60-gram quantity. This firm fixed-price delivery order, valued at $5,656.30 and due for completion by April 30, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 28, 2025, for ZORYVE 0.15% Cream in a 60-gram size. This firm fixed-price delivery order, valued at $1,018.11, represents a competitive award with no set-aside designation and carries an ultimate completion date of July 29, 2025. The contract is executed under AmerisourceBergen's broader Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,246.51 to AmerisourceBergen Drug Corp for ZORYVE 0.15% Cream 60GM, a topical pharmaceutical product. This competitively awarded, firm fixed-price delivery order was issued on July 16, 2025, with an ultimate completion date of July 17, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $1,849.81 to AmerisourceBergen Drug Corp for ZORYVE 0.3% Cream 60GM, a pharmaceutical product for federal medical procurement. The contract utilized firm fixed pricing with no set-aside designation, indicating competitive award through open competition. The award was issued on August 19, 2025, with an ultimate completion date of August 20, 2025. Performance of this delivery order takes place at AmerisourceBergen's corporate office...
- SPE2DB25D3002Indefinite Delivery Contract
- SPE2DB25D3002-SPE2DB25FLRLTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of ZORYVE 0.3% Cream in 60-gram quantities, with a contract ceiling value of $2,571.76. This is a firm fixed-price delivery order with an ultimate completion date of September 17, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order represents a small-value transaction under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. The current delivery order exemplifies the company's role in fulfilling ongoing federal medical supply requirements through this flexible contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 9/16/25 |